Brian Callaghan

Summary

Affiliation: University of Michigan
Country: USA

Publications

  1. doi request reprint The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications
    Brian Callaghan
    University of Michigan, Ann Arbor, MI 48109, USA
    Neurodegener Dis 8:1-8. 2011
  2. pmc Genotype-phenotype correlations in recessive RYR1-related myopathies
    Kimberly Amburgey
    Department of Pediatrics, Taubman Medical Research Institute, University of Michigan Medical Center, 5019 A, Alfred Taubman Biomedical Science Research Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109 2200, USA
    Orphanet J Rare Dis 8:117. 2013
  3. doi request reprint Capturing cases of distal symmetric polyneuropathy in a community
    Brian Callaghan
    Department of Neurology, University of Michigan, 109 Zina Pitcher Place, 4021 BSRB, Ann Arbor, Michigan 48104, USA
    Muscle Nerve 46:943-7. 2012
  4. doi request reprint Diabetic neuropathy: clinical manifestations and current treatments
    Brian C Callaghan
    University of Michigan, Ann Arbor, MI, USA
    Lancet Neurol 11:521-34. 2012
  5. doi request reprint Enhanced glucose control for preventing and treating diabetic neuropathy
    Brian C Callaghan
    Department of Neurology, University ofMichigan, Ann Arbor, Michigan, USA
    Cochrane Database Syst Rev 6:CD007543. 2012
  6. doi request reprint The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice
    Brian C Callaghan
    Department of Neurology, University of Michigan, 109 Zina Pitcher Place, Ann Arbor, MI 48104, USA
    Arch Neurol 69:339-45. 2012
  7. pmc Tests and expenditures in the initial evaluation of peripheral neuropathy
    Brian Callaghan
    Department of Neurology, University of Michigan, Ann Arbor, MI 48104, USA
    Arch Intern Med 172:127-32. 2012
  8. pmc Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study
    Brian C Callaghan
    University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 34:635-40. 2011
  9. pmc Remission and relapse in a drug-resistant epilepsy population followed prospectively
    Brian Callaghan
    University of Michigan, Ann Arbor, Michigan, USA
    Epilepsia 52:619-26. 2011
  10. pmc The metabolic syndrome and neuropathy: therapeutic challenges and opportunities
    Brian Callaghan
    Department of Neurology, University of Michigan, Ann Arbor, MI
    Ann Neurol 74:397-403. 2013

Collaborators

Detail Information

Publications11

  1. doi request reprint The association of exposure to lead, mercury, and selenium and the development of amyotrophic lateral sclerosis and the epigenetic implications
    Brian Callaghan
    University of Michigan, Ann Arbor, MI 48109, USA
    Neurodegener Dis 8:1-8. 2011
    ..Perhaps an interaction between the metal exposure and an individual's genetic makeup is required to produce epigenetic changes that ultimately lead to ALS...
  2. pmc Genotype-phenotype correlations in recessive RYR1-related myopathies
    Kimberly Amburgey
    Department of Pediatrics, Taubman Medical Research Institute, University of Michigan Medical Center, 5019 A, Alfred Taubman Biomedical Science Research Building, 109 Zina Pitcher Place, Ann Arbor, MI 48109 2200, USA
    Orphanet J Rare Dis 8:117. 2013
    ..To date, no clear patterns have been identified in these recessive mutations, though no systematic examination has yet been performed...
  3. doi request reprint Capturing cases of distal symmetric polyneuropathy in a community
    Brian Callaghan
    Department of Neurology, University of Michigan, 109 Zina Pitcher Place, 4021 BSRB, Ann Arbor, Michigan 48104, USA
    Muscle Nerve 46:943-7. 2012
    ..Little is known about what constitutes appropriate diagnostic testing in patients with distal symmetric polyneuropathy (DSP)...
  4. doi request reprint Diabetic neuropathy: clinical manifestations and current treatments
    Brian C Callaghan
    University of Michigan, Ann Arbor, MI, USA
    Lancet Neurol 11:521-34. 2012
    ..Studies are needed to further explore this association, which has implications for the development of new treatments for this common disorder...
  5. doi request reprint Enhanced glucose control for preventing and treating diabetic neuropathy
    Brian C Callaghan
    Department of Neurology, University ofMichigan, Ann Arbor, Michigan, USA
    Cochrane Database Syst Rev 6:CD007543. 2012
    ..Enhanced glucose control is the best studied intervention for the prevention of this disabling condition but there have been no systematic reviews of the evidence...
  6. doi request reprint The evaluation of distal symmetric polyneuropathy: a physician survey of clinical practice
    Brian C Callaghan
    Department of Neurology, University of Michigan, 109 Zina Pitcher Place, Ann Arbor, MI 48104, USA
    Arch Neurol 69:339-45. 2012
    ..To define current clinical practice for evaluating distal symmetric polyneuropathy...
  7. pmc Tests and expenditures in the initial evaluation of peripheral neuropathy
    Brian Callaghan
    Department of Neurology, University of Michigan, Ann Arbor, MI 48104, USA
    Arch Intern Med 172:127-32. 2012
    ..Peripheral neuropathy is a common disorder in which an extensive evaluation is often unrevealing...
  8. pmc Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study
    Brian C Callaghan
    University of Michigan, Ann Arbor, Michigan, USA
    Diabetes Care 34:635-40. 2011
    ..To determine the association between triglyceride levels and lower-extremity amputation (LEA) risk in a large diabetic cohort...
  9. pmc Remission and relapse in a drug-resistant epilepsy population followed prospectively
    Brian Callaghan
    University of Michigan, Ann Arbor, Michigan, USA
    Epilepsia 52:619-26. 2011
    ..In addition, we determined clinical predictors of remission and relapse in this population...
  10. pmc The metabolic syndrome and neuropathy: therapeutic challenges and opportunities
    Brian Callaghan
    Department of Neurology, University of Michigan, Ann Arbor, MI
    Ann Neurol 74:397-403. 2013
    ..Just as importantly, we must continue to investigate the pathophysiology of metabolically induced nerve injury...